Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers
- 1 July 2010
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 9 (7), 717-726
- https://doi.org/10.1016/s1474-4422(10)70105-8
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- O6-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implicationsNeuro-Oncology, 2010
- Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosisActa Neuropathologica, 2010
- MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastomaNeuro-Oncology, 2009
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Applications of next-generation sequencing technologies in functional genomicsGenomics, 2008
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaNew England Journal of Medicine, 2006